Acta Pharmaceutica Sinica B

The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association

Acta Pharmaceutica Sinica B - ISSN 2211-3835
Source Normalized Impact per Paper (SNIP): 1.602 Source Normalized Impact per Paper (SNIP):
SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SCImago Journal Rank (SJR): 1.396 SCImago Journal Rank (SJR):
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Volumes: Volume 7
Issues: 6 issues
ISSN: 22113835

Unavailable

This product is unavailable at this time on elsevier.com
If you would like to purchase this product, please check its availability on our sister store.

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

http://www.yxxb.com.cn:8081/apsb/EN/volumn/current.shtmlActa Pharmaceutica Sinica B (APSB) is a bimonthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences — including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.

http://www.yxxb.com.cn:8081/apsb/EN/volumn/current.shtmlAPSB is a series of journal of Acta Pharmaceutica Sinica, which was founded in 1953, indexed in Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, Current Bibliography on Science and Technology, etc. It sponsored by http://www.imm.ac.cnInsititute of Materia Medica, Chineses Acedemy of Medical Sciences and http://www.cpa.org.cn/Index.htmlChinese Pharmaceutical Association, production and hosting by Elsevier B. V.